(Q33648502)

English

Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Xing Li

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yan-Fang Xing

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ai-Hua Lei

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Qiang Xiao

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhi-Huan Lin

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ying-Fen Hong

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xiang-Yuan Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jie Zhou

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

17 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

24380-24388

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Kinetics of human myeloid-derived suppressor cells after blood draw

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Heterogeneity of hepatocellular carcinoma contributes to cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

History of myeloid-derived suppressor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

21 June 2018

Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

30 October 2018

Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

30 October 2018

Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5421855

30 October 2018

Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumor molecular and phenotypic diversity in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model

1 reference

https://pubmed.ncbi.nlm.nih.gov/28412745

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.15456

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33648502&oldid=1615399425"